Founded in Holliston, Massachusetts, Harvard Bioscience, Inc. is a global developer, manufacturer, and marketer of life sciences equipment aimed at supporting research and drug discovery. The company’s core mission is to enable the discovery, safety, and production of tomorrow's therapeutics. Harvard Bioscience offers a range of products, including the VIVAMARS Activity System, designed to enhance research efficiency. Their market focus includes academic research institutions, contract research organizations, pharmaceutical companies, and biotech firms.
Harvard Bioscience is publicly traded on NASDAQ under the ticker symbol HBIO. The company has established itself as a trusted partner for leading institutions in the life sciences sector. Notable achievements include the development of cutting-edge equipment that supports critical research and regulatory compliance. The overall impact of Harvard Bioscience is significant in advancing scientific discoveries and contributing to the development of life-saving therapies.
